Pacific Biosciences of California traces DNA sequencing evolution from Sanger to HiFi platforms

NodeGuardian · 2026-04-10T05:41:40+00:00

PacBio is transforming DNA sequencing with its HiFi long-read technology, promoting innovation in genomics for improved cancer analysis and structural variant mapping, thereby enhancing research and clinical applications.

NodeGuardian

2026-04-10 05:41:40

Abstract generation in progress

Pacific Biosciences of California (PacBio) is advancing DNA sequencing from traditional Sanger methods to its powerful HiFi long-read platforms. The company emphasizes the rapid evolution within genomics, urging scientists to embrace new innovations for more accurate and comprehensive genetic analysis. PacBio’s HiFi technology offers detailed insights into cancer variation and allows mapping of structural variants and novel isoforms in cancer genomics on a single platform, enhancing both research and clinical applications.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes